The recent challenges in global chains have highlighted the value of securing vital medications like Ivermectin. Dependence on overseas manufacturers exposes countries to potential vulnerabilities, including delivery delays, expense fluctuations, and even trade risks. Moving towards domestic sourcing of Ivermectin offers a multitude of advantages.